{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:59:29Z","timestamp":1778029169558,"version":"3.51.4"},"reference-count":40,"publisher":"FapUNIFESP (SciELO)","issue":"8","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"DOI":"10.1590\/1414-431x2020e10685","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:25:11Z","timestamp":1621887911000},"source":"Crossref","is-referenced-by-count":5,"title":["Tanshinone I inhibited growth of human chronic myeloid leukemia cells via JNK\/ERK mediated apoptotic pathways"],"prefix":"10.1590","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6226-3904","authenticated-orcid":false,"given":"Siya","family":"Sun","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University,  China; College of Pharmaceutical Science, Zhejiang Chinese Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2633-088X","authenticated-orcid":false,"given":"Lingyan","family":"Zhu","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Zhejiang Chinese Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0742-022X","authenticated-orcid":false,"given":"Mengru","family":"Lai","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Zhejiang Chinese Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3952-2730","authenticated-orcid":false,"given":"Rubin","family":"Cheng","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Zhejiang Chinese Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8041-186X","authenticated-orcid":false,"given":"Yuqing","family":"Ge","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2021]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"Radich JP","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref2","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, revised. 4th edition","author":"Swerdlow SH","year":"2017"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray F","year":"2018","journal-title":"Ca Cancer J Clin"},{"key":"ref4","first-page":"455","article-title":"Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib","volume":"41","author":"Cheng Y","year":"2018","journal-title":"Int J Mol Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.semcancer.2017.09.002","article-title":"MAPK signalling pathway in cancers: Olive products as cancer preventive and therapeutic agents","volume":"56","author":"Peluso I","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bph.12432","article-title":"JNK signalling in cancer: in need of new, smarter therapeutic targets","volume":"171","author":"Bubici C","year":"2014","journal-title":"Br J Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10238-011-0133-x","article-title":"A monoclonal antibody (Mc178-Ab) targeted to the ecto-ATP synthase \u03b2-subunit-induced cell apoptosis via a mechanism involving the MAPKase and Akt pathways","volume":"12","author":"Wang WJ","year":"2012","journal-title":"Clin Exp Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5582\/bst.2018.01293","article-title":"Daucosterol induces autophagic-dependent apoptosis in prostate cancer via JNK activation","volume":"13","author":"Gao P","year":"2019","journal-title":"Biosci Trends"},{"key":"ref9","article-title":"EM-2 inhibited autophagy and promoted G\/M phase arrest and apoptosis by activating the JNK pathway in hepatocellular carcinoma cells","author":"Jie Y","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"18383","DOI":"10.1074\/jbc.M112058200","article-title":"Activation of the c-Jun N-terminal Kinase (JNK) signaling pathway is essential during PBOX-6-induced apoptosis in chronic myelogenous leukemia (CML) cells","volume":"277","author":"Mc Gee MM","year":"2002","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1248\/bpb.b12-00537","article-title":"Activation of c-Jun N-terminal kinase mediates tanshinone IIA-induced apoptosis in KBM-5 chronic myeloid leukemia cells","volume":"36","author":"Yun SM","year":"2013","journal-title":"Biol Pharm Bull"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e12739","DOI":"10.1111\/cpr.12739","article-title":"Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K\/AKT\/mTOR pathway","volume":"53","author":"Zhou J","year":"2020","journal-title":"Cell Prolif"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1111\/jcmm.14539","article-title":"Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK\/STAT3 signalling pathway","volume":"23","author":"Wang W","year":"2019","journal-title":"J Cell Mol Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e22267","DOI":"10.1002\/jbt.22267","article-title":"Tanshinone I attenuates proliferation and chemoresistance of cervical cancer in a KRAS-dependent manner","volume":"33","author":"Dun S","year":"2019","journal-title":"J Biochem Mol Toxicol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1021\/acs.jmedchem.7b01259","article-title":"Structural modification of natural product tanshinone I leading to discovery of novel nitrogen-enriched derivatives with enhanced anticancer profile and improved drug-like properties","volume":"61","author":"Ding CY","year":"2018","journal-title":"J Med Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.2147\/OTT.S263322","article-title":"Saikosaponin D inhibits proliferation and promotes apoptosis through activation of MKK4-JNK signaling pathway in pancreatic cancer cells","volume":"13","author":"Lai MR","year":"2020","journal-title":"Onco Targets Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bcp.2019.02.028","article-title":"Andrographolide and its potent derivative exhibit anticancer effects against imatinib-resistant chronic myeloid leukemia cells by downregulating the Bcr-Abl oncoprotein","volume":"163","author":"Liao HC","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0254-6272(16)30079-6","article-title":"Compound Zhebei granules combined with chemotherapy for the treatment of refractory acute leukemia: a randomized clinical trial","volume":"36","author":"Hou L","year":"2016","journal-title":"J Tradit Chin Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3109\/10428194.2014.928934","article-title":"Cryptotanshinone acts synergistically with imatinib to induce apoptosis of human chronic myeloid leukemia cells","volume":"56","author":"Ge YQ","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00277-010-0996-z","article-title":"Inactivation of PI3k\/Akt signaling pathway and activation of caspase-3 are involved in tanshinone I-induced apoptosis in myeloid leukemia cells in vitro","volume":"89","author":"Liu JJ","year":"2010","journal-title":"Ann Hematol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3390\/ijms20051194","article-title":"Nuclear ERK: mechanism of translocation, substrates, and role in cancer","volume":"20","author":"Maik-Rachline G","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pharmthera.2013.10.001","article-title":"MEK in cancer and cancer therapy","volume":"141","author":"Neuzillet C","year":"2014","journal-title":"Pharmacol Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e8901","DOI":"10.1590\/1414-431x20198901","article-title":"SULF2 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells through the ERK\/AKT signaling pathway","volume":"53","author":"Jiang T","year":"2020","journal-title":"Braz J Med Biol Res"},{"key":"ref24","first-page":"2499","article-title":"Combination of CYP inhibitor with MEK\/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells","volume":"33","author":"Lim SM","year":"2013","journal-title":"Anticancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.apsb.2018.01.008","article-title":"Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy","volume":"8","author":"Liu F","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1158\/1535-7163.MCT-14-0669","article-title":"Dual PI3K\/mTOR inhibitors induce rapid overactivation of the MEK\/ERK pathway in human pancreatic cancer cells through suppression of mTORC2","volume":"14","author":"Soares HP","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.yexcr.2014.01.007","article-title":"Src mediates ERK reactivation in gefitinib resistance in non-small cell lung cancer","volume":"322","author":"Ochi N","year":"2014","journal-title":"Exp Cell Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e16781","DOI":"10.1371\/journal.pone.0016781","article-title":"Icaritin causes sustained ERK1\/2 activation and induces apoptosis in human endometrial cancer cells","volume":"6","author":"Tong JS","year":"2011","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/1878-0261.12186","article-title":"Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-\u03baB pathways in a model of chronic myeloid leukemia","volume":"12","author":"Chorzalska A","year":"2018","journal-title":"Mol Oncol"},{"key":"ref30","first-page":"346","article-title":"The MEK1\/2 inhibitor U0126 reverses imatinib resistance through down-regulating activation of Lyn\/ERK signaling pathway in imatinib-resistant K562R leukemia cells","volume":"69","author":"Shi R","year":"2014","journal-title":"Pharmazie"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e73672","DOI":"10.1371\/journal.pone.0073672","article-title":"Synergistic apoptosis of CML cells by buthionine sulfoximine and hydroxychavicol correlates with activation of AIF and GSH-ROS-JNK-ERK-iNOS pathway","volume":"8","author":"Chowdhury AA","year":"2013","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"108880","DOI":"10.18632\/oncotarget.22353","article-title":"Matrine inhibits BCR\/ABL mediated ERK\/MAPK pathway in human leukemia cells","volume":"8","author":"Ma L","year":"2017","journal-title":"Oncotarget"},{"key":"ref33","first-page":"819","article-title":"Bruceine D induces apoptosis in human chronic myeloid leukemia K562 cells via mitochondrial pathway","volume":"6","author":"Zhang JY","year":"2016","journal-title":"Am J Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1042\/BST20110630","article-title":"The roles of ATF2 (activating transcription factor 2) in tumorigenesis","volume":"40","author":"Gozdecka M","year":"2012","journal-title":"Biochem Soc Trans"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1080\/21691401.2019.1628038","article-title":"Molecular mechanism of miR-204 regulates proliferation, apoptosis and autophagy of cervical cancer cells by targeting ATF2","volume":"47","author":"Li N","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1002\/jcb.27734","article-title":"Inactivation of ATF-2 enhances epithelial-mesenchymal transition and gemcitabine sensitivity in human pancreatic cancer cells","volume":"120","author":"Wu XD","year":"2019","journal-title":"J Cell Biochem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e973","DOI":"10.1038\/cddis.2013.475","article-title":"The ROS\/JNK\/ATF2 pathway mediates selenite-induced leukemia NB4 cell cycle arrest and apoptosis in vitro and in vivo","volume":"4","author":"An JJ","year":"2013","journal-title":"Cell Death Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.celrep.2014.10.043","article-title":"JNK suppresses tumor formation via a gene-expression program mediated by ATF2","volume":"9","author":"Gozdecka M","year":"2014","journal-title":"Cell Rep"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/15384047.2016.1139245","article-title":"Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105","volume":"17","author":"Bates D","year":"2016","journal-title":"Cancer Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12931-020-1277-6","article-title":"6\u2032-O-galloylpaeoniflorin regulates proliferation and metastasis of non-small cell lung cancer through AMPK\/miR-299-5p\/ATF2 axis","volume":"21","author":"Gao J","year":"2020","journal-title":"Respir Res"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/bjmbr\/v54n8\/1414-431X-bjmbr-54-8-e10685.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:25:42Z","timestamp":1621887942000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2021000800611&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021]]}},"alternative-id":["S0100-879X2021000800611"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x2020e10685","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"value":"1414-431X","type":"electronic"},{"value":"0100-879X","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"e10685"}}